Flexpoint Ford Exits ArtesRx to Linden Capital Partners

Flexpoint Ford exits ArtesRx, a pharmacy operator focused on behavioral health, through a sale to Linden Capital Partners, a healthcare-focused private equity firm.

Flexpoint launched ArtesRx in 2023 with Dom Meffe, then a Senior Advisor to Flexpoint, as a vehicle for acquiring and growing pharmacies that serve patients with complicated medication needs. Over the course of the partnership, Flexpoint helped the company hire its leadership team, build a stronger sales function, and set up an in-house acquisition effort. ArtesRx has since grown from three pharmacies in one state to 16 pharmacies across 15 states.

GroveStreet first became a Flexpoint LP in 2006. Read more about the deal here.

Learn more about us or reach out to schedule a meeting.

Previous
Previous

Dunes Point Capital Exits NextGen Security to a Financial Buyer

Next
Next

Renovo Capital Sells Majority of Otodata to GI Partners